Polycystic ovarian syndrome (PCOS) is one of the most common endocrine gland illnesses in women, with an incidence range from 10% to 20 % in India. Patients experiencing PCOS experience issues involving irregular menstrual periods, hirsutism, acne, being overweight, and infertility. Long-term, low-grade inflammation has emerged as a crucial factor leading to PCOS. Insulin resistance is amplified by obesity. Inherent insulin resistance in PCOS is attributed to inappropriate reaction to insulin in metabolically active marginal tissues including adipose tissue and skeletal muscle [10]. Obese females with PCOS are more susceptible to insulin resistance, which might lead to abnormal glucose and lipid catabolism. Moreover, increasing insulin lowers the circulating amount of sex hormone-binding globulin (SHBG) and promotes free androgens, which constrains follicle formation resulting in irregular menses and infertility.
People with Polycystic Ovary Syndrome (PCOS) can monitor and manage their blood sugar levels with a number of lifestyle changes and medical treatments, including: